The vaccine plant in Embakasi will start operations early next year, the Ministry of Health has said. The government has invested between Sh1.5 and Sh2 billion in the Biovax project whose focus is to manufacture Covid-19 vaccines and other vaccines. Kenya targets the final manufacturing step which is the most critical in the overall vaccine manufacturing process called the fill-and-finish. Although it simply implies the filling of vaccines into bottles and packaging, it is an important part of biopharmaceutical manufacturing. “With imports comprising as much as 70 per cent of drugs consumed in the country, it’s time to promote local production.

Source: The Star October 13, 2022 21:40 UTC